About the Company
Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GH News
A fresh round of sideways trading continues for Guardant Health Inc (GH) Stock.
Craig Hallum raised the price target for the Guardant Health Inc (NASDAQ:GH) stock to “a Buy”. The rating was released on April 24, 2024, according to finviz. The stock was upgraded by Raymond James, ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: AlloVir (ALVR), Guardant Health (GH) and Centessa Pharmaceuticals (CNTA)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AlloVir (ALVR – Research Report), Guardant ...
Guardant Health Inc GH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Market Whales and Their Recent Bets on Guardant Health Options
An analyst from Goldman Sachs has decided to maintain their Buy rating on Guardant Health, which currently sits at a price ...
Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance and Positive Financial Outlook
Kyle Mikson CFA, an analyst from Canaccord Genuity, maintained the Buy rating on Guardant Health (GH – Research Report). The associated ...
Guardant Health preps for FDA advisory panel review of its blood-based colorectal cancer screening test
Guardant Health has its sights set on redefining how people get checked for colorectal cancer, and its blood test for catching stray tumor DNA soon has a date with the FDA. The agency has ...
Guardant Health Options Trading: A Deep Dive into Market Sentiment
Having examined the options trading patterns of Guardant Health, our attention now turns directly to the company. This shift ...
Guardant Health Inc GH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Guardant Health Shares Rise 13% After 1Q Revenue Beats Expectations
By Chris Wack Guardant Health shares were 13% higher to $22 in premarket trading on Friday after the company reported first-quarter revenue that ...
Loading the latest forecasts...